CNBC's David Faber and Jim Cramer dig into upgrades for Medtronic from multiple analysts after the company announced it was buying Covidien.
Medtronic announced it will buy Covidien for $42.9 billion. Barbara Ryan of FTI Consulting, discusses consolidation in the medical industry.
CNBC's Meg Tirrell provides insight to Medtronic's announcement it will buy Covidien, and also discusses the consolidation trends in medical device companies.
Bill George, Harvard business professor and former Medtronic CEO, shares his thoughts on Medtronic's $43 billion deal to buy the medical device maker for $93.22 per share.
CNBC's Meg Tirrell reports the latest detail on the deal as consolidation in the health care industry continues.